A 2024 comparative cohort study by Alkabbani et al
Despite its growing popularity among athletes and its wide availability through non-regulated sources, there is minimal human data available
Unlike SGLT-2 inhibitors, semaglutide does not affect urinary glucose levels or create conditions that promote bacterial growth in the urinary tract
Denmark's fortunes are, for better or worse, extremely tied to how well Novo Nordisk performs
Phase 1 Trials In a first-in-human, randomized, placebo-controlled, single ascending dose, phase 1 trial in healthy participants, retatrutide demonstrated a favourable safety profile (similar to other incretin-based therapies) and early signs of efficacy with dose-dependent WL [42]
If you carry an HSA or FSA, you may be able to use these tax-advantaged funds to cover your GLP-1 therapy through PlexusDx, making precision weight loss treatment more financially accessible